We are live on ! Find out more

696 hedge funds and large institutions have $13.5B invested in Sanofi in 2023 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 270 increasing their positions, 213 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 37

30% more call options, than puts

Call options by funds: $88.2M | Put options by funds: $68.1M

27% more repeat investments, than reductions

Existing positions increased: 270 | Existing positions reduced: 213

4% more funds holding

Funds holding: 672696 (+24)

0.22% less ownership

Funds ownership: 20.13%19.91% (-0.22%)

1% less capital invested

Capital invested by funds: $13.7B → $13.5B (-$196M)

8% less funds holding in top 10

Funds holding in top 10: 1211 (-1)

Holders
696
Holders Change
+24
Holders Change %
+3.57%
% of All Funds
11.03%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.17%
New
70
Increased
270
Reduced
213
Closed
37
Calls
$88.2M
Puts
$68.1M
Net Calls
+$20.1M
Net Calls Change
-$13.6M

SNY Hedge Fund Activity: Q3 2023 in Review

696 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2023, worth a combined $13.5B — down 1.4% from $13.7B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new SNY positions and 37 closed out — a net gain of 33 holders — while 270 added to existing stakes and 213 trimmed.

The largest buyer was Fisher Asset Management, adding an estimated $106M. The largest seller was Dodge & Cox, cutting an estimated $106M.

  • 696 institutional investors held Sanofi (SNY) as of Q3 2023, up from 672 in Q2 2023.
  • Funds reported $13.5B of Sanofi stock for Q3 2023, down 1.4% quarter-over-quarter.
  • 70 funds opened new Sanofi positions in Q3 2023 and 37 closed out, a net change of +33 holders.
  • The largest Sanofi buyer in Q3 2023 was Fisher Asset Management, an estimated $106M added.
  • The largest Sanofi seller in Q3 2023 was Dodge & Cox, an estimated $106M sold.

Based on aggregated 13F filings for Q3 2023.